Cambridge Healthtech’s 17th Annual
AI, Digital, and Emerging Technologies in Companion Diagnostics
Turning Digital Innovation into Clinical Decision-Making
August 25-26, 2026
As companion diagnostics evolve alongside increasingly personalized medicine, AI, digital tools, and emerging technologies are transforming how biomarkers are discovered, validated, and applied across therapeutic areas. Innovations in digital and computational pathology are expanding the role of companion diagnostics, while emerging biomarker strategies, particularly in complex indications, are redefining clinical development and patient stratifications. Join Cambridge Healthtech Institute’s 17th annual conference in AI, Digital, and Emerging Technologies in Companion Diagnostics, where industry experts will examine regulatory expectations, real-world implementation strategies, and best practices for integrating advanced tools into drug-diagnostic co-development. This conference brings together diagnostic developers, biopharma leaders, regulators, clinicians, and policymakers to discuss how advanced technologies and diagnostic innovation are shaping the next phase of precision medicine.
Coverage will include, but is not limited to:
- AI and computational pathology applications for predictive biomarker development
- Digital pathology for CDx applications
- Biomarker development and qualification in emerging indications, including CNS
- Multimodal biomarker integration
- Surrogate endpoints to assess drug efficacy
- Global regulatory pathways for biomarker-driven drug development
- Impacts of IVDR implementation
The deadline for priority consideration is February 2, 2026.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: